产品详情
  • 产品名称:Anti-CD272抗体

  • 产品型号:B和T**细胞衰减蛋白抗体
  • 产品厂商:KALANG
  • 产品文档:
你添加了1件商品 查看购物车
简单介绍:
Anti-CD272抗体产品质量稳定,实验效果明显,货期快,价格优惠,欢迎垂询订购!我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-CD272抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍:
Rabbit Anti-CD272
Cat. Number:
Anti-CD272抗体KL-0624R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
B and T lymphocyte attenuator Anti-CD272抗体(BTLA), an immunoglobulin domain-containing glycoprotein with two immunoreceptor tyrosine-based inhibitory motifs. BTLA is not expressed by naive T cells, but it is induced during activation and remains expressed on T helper type 1 (T(H)1) but not T(H)2 cells. Crosslinking BTLA with antigen receptors induces its tyrosine phosphorylation and association with the Src homology domain 2 (SH2)-containing protein tyrosine phosphatases SHP-1 and SHP-2, and attenuates production of interleukin 2 (IL-2). BTLA-deficient T cells show increased proliferation, and BTLA-deficient mice have increased specific antibody responses and enhanced sensitivity to experimental autoimmune encephalomyelitis. B7x, a peripheral homolog of B7, is a ligand of BTLA. Thus, BTLA is a third inhibitory receptor on T lymphocytes with similarities to cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and programmed death 1 (PD-1).
Also known as:
B and T lymphocyte associated Anti-CD272抗体protein; B and T lymphocyte attenuator; B and T lymphocyte associated; BTLA; BTLA1; CD272 antigen; FLJ16065; MGC129743; BTLA_HUMAN; B- and T-lymphocyte attenuator; B- and T-lymphocyte-associated protein; CD272.
Specificity:
Rabbit Polyclonal IgG, affinity purified by Protein A.
Reacts with: Human, Mouse, Rat, .
Immunogen: KLH conjugated synthetic peptide derived from human B and T-lymphocyte attenuator.
Predicted Molecular Weight: 28kDa.
Storage:
Shipped at 4℃, Store at -20℃ Anti-CD272抗体(Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:20-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions Anti-CD272抗体must be determined by the end user.
kl022Po01 血管内皮细胞蛋白C受体(PROCR)多克隆抗体 Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl022Ra01 血管内皮细胞蛋白C受体(PROCR)多克隆抗体 Polyclonal Antibody to Protein C Receptor, Endothelial (PROCR)
kl024Bo01 ***腺来源血管内皮生长因子(EG-VEGF)多克隆抗体 Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Hu01 ***腺来源血管内皮生长因子(EG-VEGF)多克隆抗体 Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Mu01 ***腺来源血管内皮生长因子(EG-VEGF)多克隆抗体 Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl024Ra01 ***腺来源血管内皮生长因子(EG-VEGF)多克隆抗体 Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)
kl025Bo01 嗜酸粒细胞趋化因子(ECF)多克隆抗体 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Eq01 嗜酸粒细胞趋化因子(ECF)多克隆抗体 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Gu01 嗜酸粒细胞趋化因子(ECF)多克隆抗体 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Hu01 嗜酸粒细胞趋化因子(ECF)多克隆抗体 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Mu01 嗜酸粒细胞趋化因子(ECF)多克隆抗体 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Ra01 嗜酸粒细胞趋化因子(ECF)多克隆抗体 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)
kl025Si01 嗜酸粒细胞趋化因子(ECF)多克隆抗体 Polyclonal Antibody to Eosinophil Chemotactic Factor (ECF)

标题:
内容:
联系人:
联系电话:
Email:
公司名称:
联系地址:
注:1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!

沪公网安备 31011702004399号